Viking Therapeutics
VKTX
VKTX
168 hedge funds and large institutions have $360M invested in Viking Therapeutics in 2018 Q4 according to their latest regulatory filings, with 51 funds opening new positions, 72 increasing their positions, 37 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
168
Holders Change
+20
Holders Change %
+13.51%
% of All Funds
3.75%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
51
Increased
72
Reduced
37
Closed
29
Calls
$8.42M
Puts
$6.59M
Net Calls
+$1.83M
Net Calls Change
+$3.47M
Top Buyers
1 |
Fiera Capital (Canada)
Montreal,
Quebec, Canada
|
+$11.2M |
2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$7.4M |
3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$7.09M |
4 |
BlackRock
New York
|
+$5.73M |
5 |
State Street
Boston,
Massachusetts
|
+$5.42M |
Top Sellers
1 |
![]()
Fidelity Investments
Boston,
Massachusetts
|
-$16.6M |
2 |
Janus Henderson Group
London,
United Kingdom
|
-$15.5M |
3 |
RI
RTW Investments
New York
|
-$8.71M |
4 |
DM
Deerfield Management
New York
|
-$8.01M |
5 |
NC
Nexthera Capital
New York
|
-$5.71M |